ZL0420 is a potent and selective BRD4 inhibitor, demonstrating nanomolar affinity with IC50 values of 27 nM for BD1 and 32 nM for BD2. This small molecule is a valuable chemical probe for epigenetic research, enabling the study of BRD4 function in oncology and inflammation models both in vitro and in vivo.